Marco Antonio Zago

Marco Antonio Zago

Auto-generated profile, based on publicly available information

Marco Antonio Zago

Departamento de Clínica Médica, Faculdade de Medicina, Universidade de São Paulo, 14049–900 Ribeirão Preto, SP, Brazil

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2004 in Stem Cells
Verified
Journal Article
Closed access
PDF file
RPRodrigo A. Panepucci
Rodrigo A. Panepucci
JSJorge L.C. Siufi
Jorge L.C. Siufi
WJWilson Araujo Silva Jr
Wilson Araujo Silva Jr
RPRodrigo Proto‐Siquiera
Rodrigo Proto‐Siquiera
LNLuciano Neder
Luciano Neder
MZMarco A. Zago
Marco A. Zago
Mesenchymal stem cells (MSCs) give origin to the marrow stromal environment that supports hematopoiesis. These cells present a wide range of differentiation potentials and a complex relationship with hematopoietic stem cells (HSCs) and endothelial cells. In addition to bone marrow (BM), MSCs can be obtained from other sites in the adult or the fetus. We isolate MSCs from the umbilical cord (UC) veins that are morphologically and immunophenotpically similar to MSCs obtained from the BM. In culture, these cells are capable of differentiating in vitro into adipocytes, osteoblasts, and condrocytes. The gene expression profiles of BM-MSCs and of UC-MSCs were compared by serial analysis of gene expression, then validated by reverse transcription polymerase chain reaction of selected genes. The two lineages shared almost all of the first thousand most expressed transcripts, including vimentin, galectin 1, osteonectin, collagens, transgelins, annexin A2, and MMP2. Nevertheless, a set of genes related to antimicrobial activity and to osteogenesis was more expressed in BM-MSCs, whereas higher expression in UC-MSCs was observed for genes that participate in pathways related to matrix remodeling via metalloproteinases and angiogenesis. Finally, cultured endothelial cells, CD34+ HSCs, MSCs, blood leukocytes, and bulk BM clustered together, separated from seven other normal nonhematopoietic tissues, on the basis of shared expressed genes. MSCs isolated from UC veins are functionally similar to BM-MSCs, but differentially expressed genes may reflect differences related to their sites of origin: BM-MSCs would be more committed to osteogenesis, whereas UC-MSCs would be more committed to angiogenesis.

1 November 2003 in Stem Cells
Verified
Journal Article
Closed access
PDF file
WJWilson Araujo Silva Jr
Wilson Araujo Silva Jr
DCDimas T. Covas
Dimas T. Covas
RPRodrigo A. Panepucci
Rodrigo A. Panepucci
RPRodrigo Proto‐Siqueira
Rodrigo Proto‐Siqueira
JSJorge L.C. Siufi
Jorge L.C. Siufi
MZMarco A. Zago
Marco A. Zago
Mesenchymal stem cells (MSCs) are multipotent precursors present in adult bone marrow, that differentiate into osteoblasts, adipocytes and myoblasts, and play important roles in hematopoiesis. We examined gene expression of these cells by serial analysis of gene expression, and found that collagen I, secreted protein acidic and rich in cysteine (osteonectin), transforming growth factor beta- (TGF-beta) induced, cofilin, galectin-1, laminin-receptor 1, cyclophilin A, and matrix metalloproteinase-2 are among the most abundantly expressed genes. Comparison with a library of CD34(+) cells revealed that MSCs had a larger number of expressed genes in the categories of cell adhesion molecule, extracellular and development. The two types of cells share abundant transcripts of many genes, some of which are highly expressed in myeloid progenitors (thymosin-beta 4 and beta 10, fos and jun). Interleukin-11 (IL-11), IL-15, IL-27 and IL-10R, IL-13R and IL-17R were the most expressed genes among the cytokines and their receptors in MSCs, and various interactions can be predicted with the CD34(+) cells. MSCs express several transcripts for various growth factors and genes suggested to be enriched in stem cells. This study reports the profile of gene expression in MSCs and identifies the important contribution of extracellular protein products, adhesion molecules, cell motility, TGF-beta signaling, growth factor receptors, DNA repair, protein folding, and ubiquination as part of their transcriptome.

12 January 2011 in Hepatology
Verified
Journal Article
Open access
PDF file
RCRodrigo T. Calado
Rodrigo T. Calado
JBJennifer Brudno
Jennifer Brudno
PMPaulomi Mehta
Paulomi Mehta
JKJoseph J. Kovacs
Joseph J. Kovacs
CWColin Wu
Colin Wu
NYNeal S. Young
Neal S. Young
Some patients with liver disease progress to cirrhosis, but the risk factors for cirrhosis development are unknown. Dyskeratosis congenita, an inherited bone marrow failure syndrome associated with mucocutaneous anomalies, pulmonary fibrosis, and cirrhosis, is caused by germline mutations of genes in the telomerase complex. We examined whether telomerase mutations also occurred in sporadic cirrhosis. In all, 134 patients with cirrhosis of common etiologies treated at the Liver Research Institute, University of Arizona, between May 2008 and July 2009, and 528 healthy subjects were screened for variation in the TERT and TERC genes by direct sequencing; an additional 1,472 controls were examined for the most common genetic variation observed in patients. Telomere length of leukocytes was measured by quantitative polymerase chain reaction. Functional effects of genetic changes were assessed by transfection of mutation-containing vectors into telomerase-deficient cell lines, and telomerase activity was measured in cell lysates. Nine of the 134 patients with cirrhosis (7%) carried a missense variant in TERT , resulting in a cumulative carrier frequency significantly higher than in controls ( P = 0.0009). One patient was homozygous and eight were heterozygous. The allele frequency for the most common missense TERT variant was significantly higher in patients with cirrhosis (2.6%) than in 2,000 controls (0.7%; P = 0.0011). One additional patient carried a TERC mutation. The mean telomere length of leukocytes in patients with cirrhosis, including six mutant cases, was shorter than in age-matched controls ( P = 0.0004). Conclusion: Most TERT gene variants reduced telomerase enzymatic activity in vitro . Loss-of-function telomerase gene variants associated with short telomeres are risk factors for sporadic cirrhosis. (Hepatology 2011;)

1 February 1998 in Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
RFR. F. Franco
R. F. Franco
AAA. G. Araújo
A. G. Araújo
JGJ. F. Guerreiro
J. F. Guerreiro
Jacques ElionJacques Elion
Jacques Elion
MZM. A. Zago
M. A. Zago
Summary: A recently described mutation in the methylenetetrahydrofolate reductase (MTHFR) gene (a C to T transition at nucleotide 677) is associated with a thermolabile phenotype and decreased enzyme activity. In homozygotes, the mutation is also related to hyperhomocysteinemia and increased risk for atherosclerotic disease and (apparently) venous thrombosis. The prevalence of this mutation in different human populations is unknown. We have investigated the frequency of the 677 C→T mutation in the MTHFR gene in 337 individuals (674 chromosomes) belonging to four ethnic groups: Whites, African and Brazilian Blacks, Asians and Amerindians. The frequencies of the positive allele among Whites and Asians were similar to those previously reported for Caucasian populations. The positive allele seems to be slightly rarer among the Amerindians (frequency 24.0%) in comparison to Whites and Asians, with a heterogeneous distribution among the five Indian tribes analysed. In contrast, the mutation has a very low prevalence in Blacks, especially among the African Blacks, for whom the mutation was absent in homozygosity. Our data indicate that the 677 C→T MTHFR mutation has a significantly heterogeneous distribution among different ethnic groups, a fact that may contribute to explain geographical or racial differences in the risk for vascular disease.

1 July 1996 in Annals of Human Genetics
Verified
Journal Article
Closed access
PDF file
SSS. E. B. Santos
S. E. B. Santos
ÂRÂndrea Ribeiro-Dos-Santos
Ândrea Ribeiro-Dos-Santos
DMD. Meyer
D. Meyer
MZM. A. Zago
M. A. Zago

1 February 2000 in American Journal of Hematology
Verified
Journal Article
Closed access
PDF file
MZM.A. Zago
M.A. Zago
WJWilson Araujo Silva Jr
Wilson Araujo Silva Jr
BDB. Dalle
B. Dalle
SGS. Gualandro
S. Gualandro
MHMara Hutz
Mara Hutz
RKR. Krishnamoorthy
R. Krishnamoorthy